Jennifer Tseng, MD
James B. Utley Professor
Boston University School of Medicine
Dept of Surgery

MD, University of California, San Francisco
MPH, Harvard School of Public Health




Dr. Tseng is a highly regarded surgical oncologist and gastrointestinal surgeon, whose practice encompasses the upper gastrointestinal tract. She has led a group of diverse BIDMC faculty in oncology research, education and care for GI, endocrine, breast, as well as melanomas and sarcomas, and other malignancies.

Dr. Tseng has published more than 100 peer-reviewed journal articles on reducing surgical risk, cancer biomarkers and on developing models for cancer treatment sequencing strategies, with a strong focus on racial and socioeconomic disparities in care, an important BMC and BUSM mission. She has collaborated with the Massachusetts Department of Public Health to assess the impact of factors including insurance, disparities and health care reform on cancer diagnosis, treatment and prevention. She was the Founding Director of SOAR (Surgical Outcomes Analysis & Research) at UMass in 2007, a research initiative to improve treatment strategies for a broad range of surgical conditions and to develop tools to assess and reduce risk. At BIDMC, she and her co-leaders have led the continued development of SOAR as a health services and outcomes research group.

Dr. Tseng is also a dedicated educator of medical students and residents who has mentored numerous trainees throughout her research career.

Chair
Boston University School of Medicine
Surgery


Chief
Boston Medical Center
Surgery







Yr Title Project-Sub Proj Pubs
2001 DEVELOPMENT OF PANCREATIC TUMOR VACCINES 5F32CA086420-02 3
2000 DEVELOPMENT OF PANCREATIC TUMOR VACCINES 1F32CA086420-01 3
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Sridhar P, Misir P, Kwak H, deGeus SW, Drake FT, Cassidy MR, McAneny DA, Tseng JF, Sachs TE. Impact of Race, Insurance Status, and Primary Language on the Presentation, Treatment, and Outcomes of Patients with Pancreatic Adenocarcinoma at a Safety-Net Hospital. J Am Coll Surg. 2019 Jun 15.View Related Profiles. PMID: 31212101.
     
  2. Feeney T, Cassidy M, Tripodis Y, McAneny D, Kavanah M, Sachs T, Tseng JF, Drake FT. Association of Primary Language with Outcomes After Operations Typically Performed to Treat Cancer: Analysis of a Statewide Database. Ann Surg Oncol. 2019 Jun 11.View Related Profiles. PMID: 31187361.
     
  3. Egyud MR, Tseng JF, Suzuki K. Multidisciplinary Therapy of Esophageal Cancer. Surg Clin North Am. 2019 Jun; 99(3):419-437.View Related Profiles. PMID: 31047033.
     
  4. Klompmaker S, van der Vliet WJ, Thoolen SJ, Ore AS, Verkoulen K, Solis-Velasco M, Canacari EG, Kruskal JB, Khwaja KO, Tseng JF, Callery MP, Kent TS, Moser AJ. Procedure-specific Training for Robot-assisted Distal Pancreatectomy. Ann Surg. 2019 Mar 28. PMID: 30946088.
     
  5. Paracha M, Van Orden K, Patts G, Tseng J, McAneny D, Sachs T. Opportunity Lost? Diagnostic Laparoscopy in Patients with Pancreatic Cancer in the National Surgical Quality Improvement Program Database. World J Surg. 2019 Mar; 43(3):937-943.View Related Profiles. PMID: 30478680.
     
  6. Watkins AA, Castillo-Angeles M, Calvillo-Ortiz R, Guetter CR, Eskander MF, Ghaffarpasand E, Anguiano-Landa L, Tseng JF, Moser AJ, Callery MP, Kent TS. Braden scale for pressure ulcer risk predicts rehabilitation placement after pancreatic resection. HPB (Oxford). 2018 Dec 31. PMID: 30606683.
     
  7. van Roessel S, Kasumova GG, Verheij J, Najarian RM, Maggino L, de Pastena M, Malleo G, Marchegiani G, Salvia R, Ng SC, de Geus SW, Lof S, Giovinazzo F, van Dam JL, Kent TS, Busch OR, van Eijck CH, Koerkamp BG, Abu Hilal M, Bassi C, Tseng JF, Besselink MG. International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer. JAMA Surg. 2018 Dec 01; 153(12):e183617. PMID: 30285076.
     
  8. Sachs TE, Tseng JF. Frozen Sections in Gastric Cancer: How Negative Is the False-Negative? JAMA Surg. 2018 Oct 24.View Related Profiles. PMID: 30422233.
     
  9. van Roessel S, Tseng JF. The Prognostic Significance of Resection Margins After Pancreaticoduodenectomy. Ann Surg Oncol. 2018 Dec; 25(Suppl 3):802-803. PMID: 30264255.
     
  10. Hachey K, Morgan R, Rosen A, Rao SR, McAneny D, Tseng J, Doherty G, Sachs T. Quality Comes with the (Anatomic) Territory: Evaluating the Impact of Surgeon Operative Mix on Patient Outcomes After Pancreaticoduodenectomy. Ann Surg Oncol. 2018 Dec; 25(13):3795-3803.View Related Profiles. PMID: 30187279.
     
Showing 10 of 151 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 151 publications over 22 distinct years, with a maximum of 22 publications in 2010

YearPublications
19951
19962
19972
19992
20001
20022
20042
20053
20063
20076
20086
200919
201022
20119
20127
20138
20144
20157
201615
201711
201814
20195
Contact for Mentoring:

830 Harrison Avenue (Moakley), Suite 3400
Boston MA 02118
Google Map


Tseng's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department